These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 2182540)

  • 41. Virulence-associated factors in Escherichia coli strains isolated from children with urinary tract infections.
    Siegfried L; Kmetová M; Puzová H; Molokácová M; Filka J
    J Med Microbiol; 1994 Aug; 41(2):127-32. PubMed ID: 7913974
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys.
    Tseng CC; Huang JJ; Wang MC; Wu AB; Ko WC; Chen WC; Wu JJ
    Kidney Int; 2007 Apr; 71(8):764-70. PubMed ID: 17290293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Organization of aerobactin, hemolysin, and antibacterial resistance genes in lactose-negative Escherichia coli strains of serotype O4 isolated from children with diarrhea.
    Colonna B; Ranucci L; Fradiani PA; Casalino M; Calconi A; Nicoletti M
    Infect Immun; 1992 Dec; 60(12):5224-31. PubMed ID: 1452355
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Escherichia coli hemolysin mutants with altered target cell specificity.
    Pellett S; Welch RA
    Infect Immun; 1996 Aug; 64(8):3081-7. PubMed ID: 8757837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Frequency and organization of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli.
    Plos K; Carter T; Hull S; Hull R; Svanborg Edén C
    J Infect Dis; 1990 Mar; 161(3):518-24. PubMed ID: 1968935
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli.
    Beutin L; Montenegro MA; Orskov I; Orskov F; Prada J; Zimmermann S; Stephan R
    J Clin Microbiol; 1989 Nov; 27(11):2559-64. PubMed ID: 2681256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Detection of pap, sfa and afa adhesin-encoding operons in uropathogenic Escherichia coli strains: relationship with expression of adhesins and production of toxins.
    Blanco M; Blanco JE; Alonso MP; Mora A; Balsalobre C; Muñoa F; Juárez A; Blanco J
    Res Microbiol; 1997 Dec; 148(9):745-55. PubMed ID: 9765858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of haemolytic Escherichia coli with particular reference to production of cytotoxic necrotizing factor type 1 (CNF1).
    Blanco J; Blanco M; Alonso MP; Blanco JE; González EA; Garabal JI
    Res Microbiol; 1992; 143(9):869-78. PubMed ID: 1363736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hemolytically active (acylated) alpha-hemolysin elicits interleukin-1beta (IL-1beta) but augments the lethality of Escherichia coli by an IL-1- and tumor necrosis factor-independent mechanism.
    Gleason TG; Houlgrave CW; May AK; Crabtree TD; Sawyer RG; Denham W; Norman JG; Pruett TL
    Infect Immun; 1998 Sep; 66(9):4215-21. PubMed ID: 9712770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of Escherichia coli hemolysins conferring quantitative differences in virulence.
    Welch RA; Falkow S
    Infect Immun; 1984 Jan; 43(1):156-60. PubMed ID: 6317564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Internalization of Escherichia coli into human renal tubular epithelial cells.
    Warren JW; Mobley HL; Trifillis AL
    J Infect Dis; 1988 Jul; 158(1):221-3. PubMed ID: 3292659
    [No Abstract]   [Full Text] [Related]  

  • 52. Phenotypic differences and characteristics of pyelonephritogenic strains of Escherichia coli isolated from children and adults.
    Jacobson SH; Katouli M; Tullus K; Brauner A
    J Infect; 1990 Nov; 21(3):279-86. PubMed ID: 2273274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Urovirulence determinants in Escherichia coli strains causing prostatitis.
    Andreu A; Stapleton AE; Fennell C; Lockman HA; Xercavins M; Fernandez F; Stamm WE
    J Infect Dis; 1997 Aug; 176(2):464-9. PubMed ID: 9237713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Escherichia coli virulence factors and serotypes in acute bacterial prostatitis.
    Terai A; Yamamoto S; Mitsumori K; Okada Y; Kurazono H; Takeda Y; Yoshida O
    Int J Urol; 1997 May; 4(3):289-94. PubMed ID: 9255669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defining genomic islands and uropathogen-specific genes in uropathogenic Escherichia coli.
    Lloyd AL; Rasko DA; Mobley HL
    J Bacteriol; 2007 May; 189(9):3532-46. PubMed ID: 17351047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo cytokine response to Escherichia coli alpha-hemolysin determined with genetically engineered hemolytic and nonhemolytic E. coli variants.
    May AK; Sawyer RG; Gleason T; Whitworth A; Pruett TL
    Infect Immun; 1996 Jun; 64(6):2167-71. PubMed ID: 8675322
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distribution of uropathogenic virulence factors among Escherichia coli strains isolated from dogs and cats.
    Yuri K; Nakata K; Katae H; Yamamoto S; Hasegawa A
    J Vet Med Sci; 1998 Mar; 60(3):287-90. PubMed ID: 9560773
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro cytotoxic effect of alpha-hemolytic Escherichia coli on human blood granulocytes.
    Gadeberg OV; Orskov I
    Infect Immun; 1984 Jul; 45(1):255-60. PubMed ID: 6376357
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of RTX toxin target cell specificity domains by use of hybrid genes.
    Forestier C; Welch RA
    Infect Immun; 1991 Nov; 59(11):4212-20. PubMed ID: 1937778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of Escherichia coli alpha-hemolysin and bacterial adherence in infection: requirement for release of inflammatory mediators from granulocytes and mast cells.
    König B; König W; Scheffer J; Hacker J; Goebel W
    Infect Immun; 1986 Dec; 54(3):886-92. PubMed ID: 2430890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.